Evidence map›Paper›PMID 41578212›Full record

ReviewBMC neurology2026

A novel de novo RNF13 variant in developmental and epileptic encephalopathy 73: genotype-phenotype correlation and literature review.

Qiang Zhang, Qi Yang, Xunzhao Zhou, Shujie Zhang, Yiyan Ruan, Jingsi Luo

Abstract readReviewCase Reports
In one paragraph

Review in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Functional Characterization of Loss ofInternational journal of molecular sciences · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Qiang Zhang *Guangxi Key Laboratory of Birth Defects Research and Prevention, Guangxi Key Laboratory of Reproductive Health and Birth Defects Prevention, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Qi Yang *Guangxi Key Laboratory of Birth Defects Research and Prevention, Guangxi Key Laboratory of Reproductive Health and Birth Defects Prevention, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Xunzhao ZhouGuangxi Key Laboratory of Birth Defects Research and Prevention, Guangxi Key Laboratory of Reproductive Health and Birth Defects Prevention, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Shujie ZhangGuangxi Key Laboratory of Birth Defects Research and Prevention, Guangxi Key Laboratory of Reproductive Health and Birth Defects Prevention, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Yiyan RuanGuangxi Key Laboratory of Birth Defects Research and Prevention, Guangxi Key Laboratory of Reproductive Health and Birth Defects Prevention, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Jingsi LuoGuangxi Key Laboratory of Birth Defects Research and Prevention, Guangxi Key Laboratory of Reproductive Health and Birth Defects Prevention, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, China. 1270319085@qq.com.

Funding

Guangxi Clinical Research Center for Pediatric Diseases Guike AD22035121Guangxi Key Laboratory of Birth Defects and Stem Cell Biobank ZTJ2020002Guangxi Key Laboratory of reproductive health and birth defect prevention 21-220-22Guangxi Zhuang Autonomous Region Health Department Z20220256Guangxi Zhuang Autonomous Region Health Department Z-A20230305Guangxi Zhuang Region Health Department Z20190311Liaoning Province Applied Basic Research Program Project 2023JH2/101300044
6 · The paper itself

Abstract

backgroundDevelopmental and epileptic encephalopathy-73 (DEE73, OMIM: #618379) is a rare autosomal dominant genetic disorder. This study reports a novel de novo RNF13 variant in a Chinese patient, aiming to assess its pathogenicity and expand understanding of the phenotypic and molecular spectrum of DEE73.

methodsWhole-exome sequencing was performed on the patient to identify candidate variants associated with the clinical phenotype. Putative pathogenic variants were validated by Sanger sequencing. In silico prediction tools were used to assess the functional impact of the identified variant. A literature review was conducted to summarize the clinical features of the 7 previously reported cases of DEE73.

resultsA novel likely pathogenic frameshift variant, c.929del/p.(Pro310fs*3), in RNF13 was identified in the patient. The clinical presentation was consistent with the diagnostic features of DEE73, yet also exhibited phenotypic heterogeneity, including severe scoliosis and pectus carinatum. A literature review confirmed that the core clinical features of DEE73 include microcephaly, seizures, developmental delay, joint contractures, abnormal muscle tone and electroencephalogram abnormalities.

conclusionsThis study expands the known genetic spectrum of DEE73 and enhances the understanding of phenotypic characteristics associated with RNF13 variants. The findings have important implications for improving variant-based screening, genetic diagnosis, and insights into the molecular mechanisms of RNF13-related disorders.

Indexed as

Developmental DisabilitiesEpilepsyUbiquitin-Protein LigasesExome SequencingFemaleGenetic Association StudiesHumansMalePhenotypeUbiquitin-Protein LigasesDevelopmental and epileptic encephalopathy 73Genetic analysisNovel variantRNF13Whole-exome sequencing

Identifiers

PMID41578212
PMCPMC12911162

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.